COVFLUVAX Trademark

Trademark Overview


On Friday, June 14, 2024, a trademark application was filed for COVFLUVAX with the United States Patent and Trademark Office. The USPTO has given the COVFLUVAX trademark a serial number of 98601149. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, November 7, 2024. This trademark is owned by ModernaTx, Inc.. The COVFLUVAX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
covfluvax

General Information


Serial Number98601149
Word MarkCOVFLUVAX
Filing DateFriday, June 14, 2024
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, November 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameModernaTx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Friday, June 14, 2024NEW APPLICATION ENTERED
Friday, June 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 17, 2024TEAS PETITION TO DIRECTOR RECEIVED
Monday, June 24, 2024ASSIGNED TO PETITION STAFF
Wednesday, July 3, 2024PETITION TO DIRECTOR GRANTED
Tuesday, July 9, 2024ASSIGNED TO EXAMINER
Wednesday, July 17, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 17, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 7, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, November 7, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Related Keywords


covfluvax human vaccines